A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastoma

Glioblastoma is the most malignant tumor and has high mortality rate. The methylated prompter of MGMT results in chemotherapy sensitivity for these patients. However, there are still other factors that affected the prognosis for the glioblastoma patients with similar MGMT methylation status. We deve...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Wang, Wen, Zhang, Lu, Wang, Zheng, Yang, Fan, Wang, Haoyuan, Liang, Tingyu, Wu, Fan, Lan, Qing, Wang, Jiangfei, Zhao, Jizong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2016
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342529/
https://ncbi.nlm.nih.gov/pubmed/27588397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11726
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak